| Literature DB >> 32178353 |
Cheng Fu1,2,3,4, Shaotang Ye1,3,4, Yongbo Liu1,3,4, Shoujun Li1,3,4.
Abstract
MDA5 belongs to theEntities:
Keywords: MDA5; antiviral activity; canine influenza virus; innate immunity
Mesh:
Substances:
Year: 2020 PMID: 32178353 PMCID: PMC7150756 DOI: 10.3390/v12030307
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Primers to identify each functional domain of MDA5.
| Primer Name | Sequence of Oligonucleotides 5′~3′ |
|---|---|
| MDA5△NRD-F | GAATTCAATGATGTGGAGCGGCCGC |
| MDA5△NRD-R | GGATCCTCAGTTTTCCTTGTAACACTTTGCAGC |
| MDA5△CARD-F | GAATTCAATGACTTGCTTTGAAAGCAAAGAAG |
| MDA5△CARD-R | GGATCCTCATCAATCCTCATCACTAAACAAAC |
| MDA5△NRD+CARD-F | GAATTCAATGACTTGCTTTGAAAGCAAAGAAG |
| MDA5△NRD+CARD-R | GGATCCTCAGTTTTCCTTGTAACACTTTGC |
| MDA5-CARD-F | GAATTCAATGATGTGGAGCGGCCGC |
| MDA5-CARD-R | GGATCCTCATGTGCCTGTTAGCTCTTGGAC |
| MDA5-F | GAATTCAATGATGTGGAGCGGCCGC |
| MDA5-R | GGATCCTCATCAATCCTCATCACTAAACAAAC |
Primers used for RT-qPCR analysis.
| Primer Name | Forward Primer (5′~3′) | Reverse Primer (5′~3′) |
|---|---|---|
| IL-1B | TCAAGAACACAGTGGAATTTGAGTCTT | TCAGTTATATCCTGGCCACCTCTG |
| IL-6 | TTCATTCCTTAGGATAGTGCTGAG | TCCTGAGGAGTGAAGATAACAATTT |
| IL-8 | AAACACACTCCACACCTTTCCAT | GGCACACCTCATTTCCATTGAA |
| IL-2 | AGTAACCTCAACTCCTGCCACAAT | TTGCTCCATCTGTTGCTCTGTTTC |
| RIG-I | CTCCAAGAAGAAGGCTGGTTC | AAGCAATCTATACTCCTCTAGACTTTC |
| LGP2 | TCACTCCCTCCTACTCTGGCTC | TTTCGGATCACTTCTTGCTGGTCT |
| MX1 | ATCACTGACTCGAATCCTGTACCC | GCCTACCTTCTCCTCATATTGGCT |
| OAS | CCAGGGTAACTCAGGAAGGAAAGT | CATCTCCATCAAACACGGGCTG |
| STA1 | TTGACAGCAAAGTGAGAAACGTGA | ATTGGCTTCATGTTCTCGGTTCTG |
| IFN-β | GAAATCACGCCAGTTCCAGAAG | TCTCATTCCATCCTGTTCTAGAGATATT |
| TRIM25 | TGAAACACTATATCAGGCAGTCCC | AAATGTATGGGTTTGTGCGTGGAT |
| TNF | CCCTGGTACGAGCCCATCTAC | AATGATTCCAAAGTACACCTGCCC |
| IPS1 | GACCACAAGATGTCCGCAAGC | GGCAAGCTGTCTCTGGTGGA |
siRNA sequence used in RNA interference assays.
| Name | Sequence of Oligonucleotides (5′~3′) |
|---|---|
| siMDA5-1 | GACTGAGAATTTATCACAA |
| siMDA5-2 | GTAGTTTCAGAATCAGACA |
| siMDA5-3 | GTCATCACACCAACAAAGA |
Figure 1Characteristics of canine MDA5. (A) Amino acid alignment of felis (XP_011283648.1), human (NP_071451.2), mouse (NP_001157949.1), and chicken (NP_001180567.1). Alignment with clustal X program and edited with Boxshade. Dark shading indicates the same amino acid. The CARD, DEXDc, HELICc, and RIG-I_C-RD regions are indicated. (B) Tissue distribution of canine MDA5 in healthy dogs. The data are expressed as MDA5 mRNA relative expression, with the expression level of MDA5 in the heart serving as a control. Data were tested by one-way ANOVA with Fisher’s least significant difference (LSD) post hoc correction. * p < 0.05; ** p < 0.01; *** p < 0.001. Error bars indicate standard deviation. (C) Tissue distribution of MDA5 after infection with H3N2 CIV. Tissue distribution of MDA5 on the third (Day 3) and seventh (Day 7) day after infection with H3N2 CIV; the controls were inoculated with PBS. The relative MDA5 expression was calculated using the 2-ΔΔCt method. Data were tested by one-way ANOVA with Fisher’s least significant difference (LSD) post-hoc correction. * p < 0.05; ** p < 0.01; *** p < 0.001. Error bars indicate standard deviation. (D) Canine MDA5 subcellular localization. MDCK cells were transfected with p3xFLAG-MDA5 (2.5 μg/well) in a 14 mm-confocal dish. After 36 h, cells were fixed and stained. MDA5 was detected with mouse anti-flag antibody and Alexa Fluor 488-labeled Goat Anti-Mouse IgG (H+L). The result was obtained by laser confocal microscopy.
Figure 2Effect of MDA5 and MDA5 CARD region on viral replication. (A) MDA5 mRNA was determined by RT-qPCR after transfection with siRNA and plasmid. Data were tested by one-way ANOVA with Fisher’s least significant difference (LSD) post- hoc correction. * p < 0.05; ** p < 0.01; *** p < 0.001. Error bars indicate standard deviation. (B) MDCK cells were transiently transfected with 2.5 μg/well p3xFLAG-MDA5-CARD, p3xFLAG-MDA5, and p3xFLAG in 6-well plates. After 24 h, MDCK cells were infected with 0.01 MOI doses of H3N2 CIV, and supernatants were collected at 24 h, 36 h, and 48 h after infection. The replication titer of the virus was detected by TCID50. (C) After transient transfection 2.5 μg/well of siMDA5-2 and siNC in 6-well plates, MDCK cells were infected with CIV 24 h later, and viral supernatants were collected at different time point (24 h, 36 h, 48 h) to detect viral replication by TCID50. (D) Different doses (2.5 μg, 5.0 μg, 10 μg) of p3xFLAG-MDA5 were transiently transfected. After 24 h, cells were infected with influenza virus at a dose of 0.01 MOI. After 36 h, the supernatant was collected to detect the expression of influenza virus NP protein and MDA5. Western blot analysis was used antibodies against Flag, GAPDH and viral NP. NP mRNA expression was tested by RT-qPCR. Data were tested by one-way ANOVA with Fisher’s least significant difference (LSD) post-hoc correction. * p < 0.05; ** p < 0.01; *** p < 0.001. Error bars indicate standard deviation.
Figure 3Effect of canine MDA5 domain on IFN-β/IRF3 and NF-κB promoter. p3xFLAG, p3xFLAG-MDA5-CARD, p3xFLAG-MDA5-ΔCARD, p3xFLAG-MDA5-ΔRD, p3xFLAG-MDA5-CARD+RD, p3xFLAG-MDA5 (500 ng/well), and poly I:C (500 ng/well) were transfected with pGL3-IFN-β (100 ng/well) (A), pGL3-NF-κB (100 ng/well) (B), pGL3-IRF3 (100 ng/well) (C), and pRL-TK (50 ng/well) in 24-well plates. Following, cells were harvested, and the relative fluorescein expression levels of IFN-β were measured after 36 h. Poly I:C represent a positive control. Data were tested by one-way ANOVA with Fisher’s least significant difference (LSD) post-hoc correction. * p < 0.05; ** p < 0.01; *** p < 0.001. Error bars indicate standard deviation. (D) The protein expression of five plasmids in MDCK cells was detected by western blot, and the GAPDH was used as a control.
Figure 4MDCK cellular response to p3xFLAG-CARD, p3xFLAG-MDA5, p3xFLAG, and poly I:C overexpression. The relative mRNA expression of (A) antiviral molecules (IPS1, Mx, OAS, STAT1), (B) proinflammatory cytokines (IFN-β, IL-1β, IL-2, IL-6, IL-8), and (C) RLR (LGP2 and RIG-I) was determined by RT-qPCR after 36 h transfection with p3xFLAG-CARD and p3xFLAG-MDA5 (2.5 μg/well) in 6-well plates. Poly I:C (2.5 μg/well) represents a positive control. Data were tested by one-way ANOVA with Fisher’s least significant difference (LSD) post-hoc correction. ** p < 0.01; *** p < 0.001. Error bars indicate standard deviation.
Figure 5SiMDA5 attenuates antiviral activity. The effect of MDA5 after silencing against viral proteins. MDCK cells were transfected with siNC or siMDA5 (2.5 μg/well). After 36 h, MDA5 mRNA relative expression was measured. Further, siMDA5 was transfected for 12 h, and p3xFLAG-MDA5-CARD (2.5 μg/well) was overexpressed to measure the relative MDA5 mRNA expression. Data were tested by one-way ANOVA with Fisher’s least significant difference (LSD) post-hoc correction. * p < 0.05; *** p < 0.001. Error bars indicate standard deviation.